CHPA Product Quality & Operations Workshop In Brief
This article was originally published in The Tan Sheet
Facilitating switch is CHPA’s top priority
You may also be interested in...
FDA better allocated resources for foreign inspections based on information European and Australian authorities shared in a two-year pilot program, including conducting good manufacturing practices inspections that met the needs of multiple agencies.
The next generation of consumer health products, including Rx-to-OTC switch opportunities, may work in concert with cutting-edge diagnostic tools and elements of personalized medicine, says Andrew Fish.
The Institute for Safe Medication Practices calls for FDA to make a draft guidance on dosage delivery devices for liquid OTCs more restrictive to prevent consumer misdosing via standardized devices